img

Global Psoriasis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Psoriasis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Psoriasis is a chronic non-contagious disease in which a person’s immune system sends faulty signals directing skin cells to grow too quickly.
The global Psoriasis Treatment market size was US$ 14700 million in 2024 and is forecast to a readjusted size of US$ 24560 million by 2034 with a CAGR of 7.5% during the forecast period 2024-2034.
Globally North America is the largest market of global psoriasis treatment. Europe is the second largest market for global psoriasis treatment. However the developing market is Asia Pacific that will be the fastest growing region and will be the key to the future.
In terms of sales (consumption) side, this report focuses on the sales of Psoriasis Treatment by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Psoriasis Treatment market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Psoriasis Treatment market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Novartis International AG
Johnson & Johnson
Pfizer Inc.
Merck and Co. Inc.
AbbVie and Amgen
Eli Lilly
By Type
TNF Inhibitors
Phosphodiesterase Inhibitors
Interleukin Blockers
Others
By Application
Oral
Injectable
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Psoriasis Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Psoriasis Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psoriasis Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Psoriasis Treatment Definition
1.2 Market by Type
1.2.1 Global Psoriasis Treatment Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 TNF Inhibitors
1.2.3 Phosphodiesterase Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Psoriasis Treatment Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Oral
1.3.3 Injectable
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Psoriasis Treatment Sales
2.1 Global Psoriasis Treatment Revenue Estimates and Forecasts 2018-2034
2.2 Global Psoriasis Treatment Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Psoriasis Treatment Revenue by Region
2.3.1 Global Psoriasis Treatment Revenue by Region (2018-2023)
2.3.2 Global Psoriasis Treatment Revenue by Region (2024-2034)
2.4 Global Psoriasis Treatment Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Psoriasis Treatment Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Psoriasis Treatment Sales Quantity by Region
2.6.1 Global Psoriasis Treatment Sales Quantity by Region (2018-2023)
2.6.2 Global Psoriasis Treatment Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Psoriasis Treatment Sales Quantity by Manufacturers
3.1.1 Global Psoriasis Treatment Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Psoriasis Treatment Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Psoriasis Treatment Sales in 2024
3.2 Global Psoriasis Treatment Revenue by Manufacturers
3.2.1 Global Psoriasis Treatment Revenue by Manufacturers (2018-2023)
3.2.2 Global Psoriasis Treatment Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Psoriasis Treatment Revenue in 2024
3.3 Global Psoriasis Treatment Sales Price by Manufacturers
3.4 Global Key Players of Psoriasis Treatment, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Psoriasis Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Psoriasis Treatment, Product Offered and Application
3.8 Global Key Manufacturers of Psoriasis Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Psoriasis Treatment Sales Quantity by Type
4.1.1 Global Psoriasis Treatment Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Psoriasis Treatment Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Psoriasis Treatment Sales Quantity Market Share by Type (2018-2034)
4.2 Global Psoriasis Treatment Revenue by Type
4.2.1 Global Psoriasis Treatment Historical Revenue by Type (2018-2023)
4.2.2 Global Psoriasis Treatment Forecasted Revenue by Type (2024-2034)
4.2.3 Global Psoriasis Treatment Revenue Market Share by Type (2018-2034)
4.3 Global Psoriasis Treatment Price by Type
4.3.1 Global Psoriasis Treatment Price by Type (2018-2023)
4.3.2 Global Psoriasis Treatment Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Psoriasis Treatment Sales Quantity by Application
5.1.1 Global Psoriasis Treatment Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Psoriasis Treatment Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Psoriasis Treatment Sales Quantity Market Share by Application (2018-2034)
5.2 Global Psoriasis Treatment Revenue by Application
5.2.1 Global Psoriasis Treatment Historical Revenue by Application (2018-2023)
5.2.2 Global Psoriasis Treatment Forecasted Revenue by Application (2024-2034)
5.2.3 Global Psoriasis Treatment Revenue Market Share by Application (2018-2034)
5.3 Global Psoriasis Treatment Price by Application
5.3.1 Global Psoriasis Treatment Price by Application (2018-2023)
5.3.2 Global Psoriasis Treatment Price Forecast by Application (2024-2034)
6 North America
6.1 North America Psoriasis Treatment Sales by Company
6.1.1 North America Psoriasis Treatment Revenue by Company (2018-2023)
6.1.2 North America Psoriasis Treatment Sales Quantity by Company (2018-2023)
6.2 North America Psoriasis Treatment Market Size by Type
6.2.1 North America Psoriasis Treatment Sales Quantity by Type (2018-2034)
6.2.2 North America Psoriasis Treatment Revenue by Type (2018-2034)
6.3 North America Psoriasis Treatment Market Size by Application
6.3.1 North America Psoriasis Treatment Sales Quantity by Application (2018-2034)
6.3.2 North America Psoriasis Treatment Revenue by Application (2018-2034)
6.4 North America Psoriasis Treatment Market Size by Country
6.4.1 North America Psoriasis Treatment Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Psoriasis Treatment Revenue by Country (2018-2034)
6.4.3 North America Psoriasis Treatment Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Psoriasis Treatment Sales by Company
7.1.1 Europe Psoriasis Treatment Sales Quantity by Company (2018-2023)
7.1.2 Europe Psoriasis Treatment Revenue by Company (2018-2023)
7.2 Europe Psoriasis Treatment Market Size by Type
7.2.1 Europe Psoriasis Treatment Sales Quantity by Type (2018-2034)
7.2.2 Europe Psoriasis Treatment Revenue by Type (2018-2034)
7.3 Europe Psoriasis Treatment Market Size by Application
7.3.1 Europe Psoriasis Treatment Sales Quantity by Application (2018-2034)
7.3.2 Europe Psoriasis Treatment Revenue by Application (2018-2034)
7.4 Europe Psoriasis Treatment Market Size by Country
7.4.1 Europe Psoriasis Treatment Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Psoriasis Treatment Revenue by Country (2018-2034)
7.4.3 Europe Psoriasis Treatment Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Psoriasis Treatment Sales by Company
8.1.1 China Psoriasis Treatment Sales Quantity by Company (2018-2023)
8.1.2 China Psoriasis Treatment Revenue by Company (2018-2023)
8.2 China Psoriasis Treatment Market Size by Type
8.2.1 China Psoriasis Treatment Sales Quantity by Type (2018-2034)
8.2.2 China Psoriasis Treatment Revenue by Type (2018-2034)
8.3 China Psoriasis Treatment Market Size by Application
8.3.1 China Psoriasis Treatment Sales Quantity by Application (2018-2034)
8.3.2 China Psoriasis Treatment Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Psoriasis Treatment Sales by Company
9.1.1 APAC Psoriasis Treatment Sales Quantity by Company (2018-2023)
9.1.2 APAC Psoriasis Treatment Revenue by Company (2018-2023)
9.2 APAC Psoriasis Treatment Market Size by Type
9.2.1 APAC Psoriasis Treatment Sales Quantity by Type (2018-2034)
9.2.2 APAC Psoriasis Treatment Revenue by Type (2018-2034)
9.3 APAC Psoriasis Treatment Market Size by Application
9.3.1 APAC Psoriasis Treatment Sales Quantity by Application (2018-2034)
9.3.2 APAC Psoriasis Treatment Revenue by Application (2018-2034)
9.4 APAC Psoriasis Treatment Market Size by Region
9.4.1 APAC Psoriasis Treatment Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Psoriasis Treatment Revenue by Region (2018-2034)
9.4.3 APAC Psoriasis Treatment Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Psoriasis Treatment Sales by Company
10.1.1 Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Psoriasis Treatment Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Psoriasis Treatment Market Size by Type
10.2.1 Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Psoriasis Treatment Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Psoriasis Treatment Market Size by Application
10.3.1 Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Psoriasis Treatment Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Psoriasis Treatment Market Size by Country
10.4.1 Middle East, Africa and Latin America Psoriasis Treatment Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Psoriasis Treatment Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Company Information
11.1.2 Novartis International AG Overview
11.1.3 Novartis International AG Psoriasis Treatment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Novartis International AG Psoriasis Treatment Products and Services
11.1.5 Novartis International AG Psoriasis Treatment SWOT Analysis
11.1.6 Novartis International AG Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Psoriasis Treatment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Johnson & Johnson Psoriasis Treatment Products and Services
11.2.5 Johnson & Johnson Psoriasis Treatment SWOT Analysis
11.2.6 Johnson & Johnson Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Psoriasis Treatment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Pfizer Inc. Psoriasis Treatment Products and Services
11.3.5 Pfizer Inc. Psoriasis Treatment SWOT Analysis
11.3.6 Pfizer Inc. Recent Developments
11.4 Merck and Co. Inc.
11.4.1 Merck and Co. Inc. Company Information
11.4.2 Merck and Co. Inc. Overview
11.4.3 Merck and Co. Inc. Psoriasis Treatment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Merck and Co. Inc. Psoriasis Treatment Products and Services
11.4.5 Merck and Co. Inc. Psoriasis Treatment SWOT Analysis
11.4.6 Merck and Co. Inc. Recent Developments
11.5 AbbVie and Amgen
11.5.1 AbbVie and Amgen Company Information
11.5.2 AbbVie and Amgen Overview
11.5.3 AbbVie and Amgen Psoriasis Treatment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 AbbVie and Amgen Psoriasis Treatment Products and Services
11.5.5 AbbVie and Amgen Psoriasis Treatment SWOT Analysis
11.5.6 AbbVie and Amgen Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Psoriasis Treatment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Eli Lilly Psoriasis Treatment Products and Services
11.6.5 Eli Lilly Psoriasis Treatment SWOT Analysis
11.6.6 Eli Lilly Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Psoriasis Treatment Value Chain Analysis
12.2 Psoriasis Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Psoriasis Treatment Production Mode & Process
12.4 Psoriasis Treatment Sales and Marketing
12.4.1 Psoriasis Treatment Sales Channels
12.4.2 Psoriasis Treatment Distributors
12.5 Psoriasis Treatment Customers
13 Market Dynamics
13.1 Psoriasis Treatment Industry Trends
13.2 Psoriasis Treatment Market Drivers
13.3 Psoriasis Treatment Market Challenges
13.4 Psoriasis Treatment Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Psoriasis Treatment Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of TNF Inhibitors
Table 3. Major Manufacturers of Phosphodiesterase Inhibitors
Table 4. Major Manufacturers of Interleukin Blockers
Table 5. Major Manufacturers of Others
Table 6. Global Psoriasis Treatment Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Psoriasis Treatment Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Psoriasis Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Psoriasis Treatment Revenue Market Share by Region (2018-2023)
Table 10. Global Psoriasis Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Psoriasis Treatment Revenue Market Share by Region (2024-2034)
Table 12. Global Psoriasis Treatment Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 13. Global Psoriasis Treatment Sales by Region (2018-2023) & (K Units)
Table 14. Global Psoriasis Treatment Sales Market Share by Region (2018-2023)
Table 15. Global Psoriasis Treatment Sales by Region (2024-2034) & (K Units)
Table 16. Global Psoriasis Treatment Sales Market Share by Region (2024-2034)
Table 17. Global Psoriasis Treatment Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 18. Global Psoriasis Treatment Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Psoriasis Treatment Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Psoriasis Treatment Revenue Share by Manufacturers (2018-2023)
Table 21. Global Psoriasis Treatment Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Key Players of Psoriasis Treatment, Industry Ranking, 2021 VS 2024
Table 23. Global Psoriasis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Psoriasis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Treatment as of 2024)
Table 25. Global Key Manufacturers of Psoriasis Treatment, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Psoriasis Treatment, Product Offered and Application
Table 27. Global Key Manufacturers of Psoriasis Treatment, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 30. Global Psoriasis Treatment Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Psoriasis Treatment Sales Quantity Share by Type (2018-2023)
Table 32. Global Psoriasis Treatment Sales Quantity Share by Type (2024-2034)
Table 33. Global Psoriasis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Psoriasis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Psoriasis Treatment Revenue Share by Type (2018-2023)
Table 36. Global Psoriasis Treatment Revenue Share by Type (2024-2034)
Table 37. Psoriasis Treatment Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Psoriasis Treatment Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Psoriasis Treatment Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Psoriasis Treatment Sales Quantity Share by Application (2018-2023)
Table 42. Global Psoriasis Treatment Sales Quantity Share by Application (2024-2034)
Table 43. Global Psoriasis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Psoriasis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Psoriasis Treatment Revenue Share by Application (2018-2023)
Table 46. Global Psoriasis Treatment Revenue Share by Application (2024-2034)
Table 47. Psoriasis Treatment Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Psoriasis Treatment Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Psoriasis Treatment Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Psoriasis Treatment Sales Quantity by Company (2018-2023) & (K Units)
Table 51. North America Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 52. North America Psoriasis Treatment Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Psoriasis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Psoriasis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 56. North America Psoriasis Treatment Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Psoriasis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Psoriasis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Psoriasis Treatment Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Psoriasis Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Psoriasis Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Psoriasis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 63. North America Psoriasis Treatment Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Psoriasis Treatment Sales Quantity by Company (2018-2023) & (K Units)
Table 65. Europe Psoriasis Treatment Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Europe Psoriasis Treatment Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Psoriasis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Psoriasis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Psoriasis Treatment Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Psoriasis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Psoriasis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Psoriasis Treatment Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Psoriasis Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Psoriasis Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Psoriasis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Psoriasis Treatment Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Psoriasis Treatment Sales Quantity by Company (2018-2023) & (K Units)
Table 80. China Psoriasis Treatment Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 82. China Psoriasis Treatment Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Psoriasis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Psoriasis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 86. China Psoriasis Treatment Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Psoriasis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Psoriasis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Psoriasis Treatment Sales Quantity by Company (2018-2023) & (K Units)
Table 90. APAC Psoriasis Treatment Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 92. APAC Psoriasis Treatment Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Psoriasis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Psoriasis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 96. APAC Psoriasis Treatment Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Psoriasis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Psoriasis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Psoriasis Treatment Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Psoriasis Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Psoriasis Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Psoriasis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 103. APAC Psoriasis Treatment Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Company (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Psoriasis Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Novartis International AG Company Information
Table 120. Novartis International AG Description and Overview
Table 121. Novartis International AG Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 122. Novartis International AG Psoriasis Treatment Product and Services
Table 123. Novartis International AG Psoriasis Treatment SWOT Analysis
Table 124. Novartis International AG Recent Developments
Table 125. Johnson & Johnson Company Information
Table 126. Johnson & Johnson Description and Overview
Table 127. Johnson & Johnson Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 128. Johnson & Johnson Psoriasis Treatment Product and Services
Table 129. Johnson & Johnson Psoriasis Treatment SWOT Analysis
Table 130. Johnson & Johnson Recent Developments
Table 131. Pfizer Inc. Company Information
Table 132. Pfizer Inc. Description and Overview
Table 133. Pfizer Inc. Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 134. Pfizer Inc. Psoriasis Treatment Product and Services
Table 135. Pfizer Inc. Psoriasis Treatment SWOT Analysis
Table 136. Pfizer Inc. Recent Developments
Table 137. Merck and Co. Inc. Company Information
Table 138. Merck and Co. Inc. Description and Overview
Table 139. Merck and Co. Inc. Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 140. Merck and Co. Inc. Psoriasis Treatment Product and Services
Table 141. Merck and Co. Inc. Psoriasis Treatment SWOT Analysis
Table 142. Merck and Co. Inc. Recent Developments
Table 143. AbbVie and Amgen Company Information
Table 144. AbbVie and Amgen Description and Overview
Table 145. AbbVie and Amgen Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 146. AbbVie and Amgen Psoriasis Treatment Product and Services
Table 147. AbbVie and Amgen Psoriasis Treatment SWOT Analysis
Table 148. AbbVie and Amgen Recent Developments
Table 149. Eli Lilly Company Information
Table 150. Eli Lilly Description and Overview
Table 151. Eli Lilly Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 152. Eli Lilly Psoriasis Treatment Product and Services
Table 153. Eli Lilly Psoriasis Treatment SWOT Analysis
Table 154. Eli Lilly Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Psoriasis Treatment Distributors List
Table 158. Psoriasis Treatment Customers List
Table 159. Psoriasis Treatment Market Trends
Table 160. Psoriasis Treatment Market Drivers
Table 161. Psoriasis Treatment Market Challenges
Table 162. Psoriasis Treatment Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Psoriasis Treatment Product Picture
Figure 2. Global Psoriasis Treatment Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Psoriasis Treatment Market Share by Type in 2024 & 2034
Figure 4. TNF Inhibitors Product Picture
Figure 5. Phosphodiesterase Inhibitors Product Picture
Figure 6. Interleukin Blockers Product Picture
Figure 7. Others Product Picture
Figure 8. Global Psoriasis Treatment Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Psoriasis Treatment Market Share by Application in 2024 & 2034
Figure 10. Oral
Figure 11. Injectable
Figure 12. Psoriasis Treatment Report Years Considered
Figure 13. Global Psoriasis Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Psoriasis Treatment Revenue 2018-2034 (US$ Million)
Figure 15. Global Psoriasis Treatment Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Psoriasis Treatment Sales Quantity 2018-2034 (K Units)
Figure 17. Global Psoriasis Treatment Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Psoriasis Treatment Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Psoriasis Treatment Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Psoriasis Treatment Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Psoriasis Treatment Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Psoriasis Treatment Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Psoriasis Treatment Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Psoriasis Treatment Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Psoriasis Treatment Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Psoriasis Treatment Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Psoriasis Treatment Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Psoriasis Treatment Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Psoriasis Treatment Revenue in 2024
Figure 31. Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Psoriasis Treatment Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Psoriasis Treatment Revenue Market Share by Type (2018-2034)
Figure 34. Global Psoriasis Treatment Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Psoriasis Treatment Revenue Market Share by Application (2018-2034)
Figure 36. North America Psoriasis Treatment Revenue Market Share by Company in 2024
Figure 37. North America Psoriasis Treatment Sales Quantity Market Share by Company in 2024
Figure 38. North America Psoriasis Treatment Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Psoriasis Treatment Revenue Market Share by Type (2018-2034)
Figure 40. North America Psoriasis Treatment Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Psoriasis Treatment Revenue Market Share by Application (2018-2034)
Figure 42. North America Psoriasis Treatment Revenue Share by Country (2018-2034)
Figure 43. North America Psoriasis Treatment Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Psoriasis Treatment Sales Quantity Market Share by Company in 2024
Figure 47. Europe Psoriasis Treatment Revenue Market Share by Company in 2024
Figure 48. Europe Psoriasis Treatment Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Psoriasis Treatment Revenue Market Share by Type (2018-2034)
Figure 50. Europe Psoriasis Treatment Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Psoriasis Treatment Revenue Market Share by Application (2018-2034)
Figure 52. Europe Psoriasis Treatment Revenue Share by Country (2018-2034)
Figure 53. Europe Psoriasis Treatment Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 55. France Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 59. China Psoriasis Treatment Sales Quantity Market Share by Company in 2024
Figure 60. China Psoriasis Treatment Revenue Market Share by Company in 2024
Figure 61. China Psoriasis Treatment Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Psoriasis Treatment Revenue Market Share by Type (2018-2034)
Figure 63. China Psoriasis Treatment Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Psoriasis Treatment Revenue Market Share by Application (2018-2034)
Figure 65. APAC Psoriasis Treatment Sales Quantity Market Share by Company in 2024
Figure 66. APAC Psoriasis Treatment Revenue Market Share by Company in 2024
Figure 67. APAC Psoriasis Treatment Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Psoriasis Treatment Revenue Market Share by Type (2018-2034)
Figure 69. APAC Psoriasis Treatment Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Psoriasis Treatment Revenue Market Share by Application (2018-2034)
Figure 71. APAC Psoriasis Treatment Revenue Share by Region (2018-2034)
Figure 72. APAC Psoriasis Treatment Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 77. India Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Psoriasis Treatment Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Psoriasis Treatment Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Psoriasis Treatment Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Psoriasis Treatment Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Psoriasis Treatment Revenue Share by Country (2018-2034)
Figure 86. Brazil Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Psoriasis Treatment Revenue (2018-2034) & (US$ Million)
Figure 91. Psoriasis Treatment Value Chain
Figure 92. Psoriasis Treatment Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed